Related Experiment Video
Updated: Jun 14, 2026

07:30
Transcanalicular Diode Laser-assisted Dacryocystorhinostomy for the Treatment of Primary Acquired Nasolacrimal Duct Obstruction
Published on: October 13, 2017
11.0K
A Retrospective CT Analysis for Prelacrimal Window Access to Maxillary Sinus
Hansol Kim1, Taesik Jung1, Joon Yong Park1
1Department of Otorhinolaryngology-Head and Neck Surgery, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea.
Journal of Rhinology : Official Journal of the Korean Rhinologic Society
|December 12, 2024
Summary
The prelacrimal window approach (PLWA) is highly feasible in Koreans (92.2%), similar to Chinese populations, and higher than in Europeans. Maxillary sinus lesion patients showed greater anterior wall thickness but similar distances compared to controls.
Area of Science:
- Otolaryngology
- Endoscopic Sinus Surgery
- Anatomical Studies
Background:
- The prelacrimal window approach (PLWA) is effective for anterior maxillary sinus lesions.
- Previous studies show higher PLWA feasibility in Chinese (93.0%) versus European (68.5%) populations.
Purpose of the Study:
- Compare PLWA ease between Korean patients with maxillary sinus lesions and healthy controls.
- Analyze Korean PLWA results against previous Chinese and European data.
Main Methods:
- Analyzed 89 paranasal CT scans (51 controls, 38 patients).
- Measured distance (D1) between maxillary sinus and lacrimal duct anterior walls and wall thickness (T).
- Compared measurements between patient and control groups.
Main Results:
- Koreans showed 92.2% PLWA feasibility, aligning with Chinese data.
- Patient group had significantly greater anterior wall thickness (T) than controls.
- Distance measures (D1, D2) were similar between patient and control groups.
Conclusions:
- PLWA is highly feasible in Koreans, comparable to Chinese populations.
- Maxillary sinus lesion presence does not significantly alter key anatomical distances for PLWA.
- Anterior wall thickness is a distinguishing factor between patients and controls.

